Summary
Synopsys, Inc. (SNPS) reported a solid performance for the fiscal year ending October 30, 2015, with revenue growing by 9% to $2.24 billion. This growth was driven by a combination of organic expansion and strategic acquisitions, particularly in the software quality and security space. The company's business model, heavily reliant on time-based revenue (approximately 90%), provides a degree of revenue predictability, although customer spending fluctuations can impact revenue recognition timing. Financially, Synopsys demonstrated strong operating income growth of 7%. However, net income saw a decrease of 13% year-over-year, primarily due to a significant increase in the provision for income taxes, influenced by acquisition integration and prior-year tax settlements. The company continued to invest heavily in research and development ($776.2 million), reflecting its commitment to innovation in the complex and rapidly evolving semiconductor design and software security markets. Synopsys also actively managed its capital through a substantial stock repurchase program, demonstrating a commitment to returning value to shareholders.
Financial Highlights
54 data points| Revenue | $2.24B |
| Cost of Revenue | $518.92M |
| Gross Profit | $1.72B |
| R&D Expenses | $776.23M |
| Operating Expenses | $1.46B |
| Operating Income | $266.47M |
| Interest Expense | $2.81M |
| Net Income | $225.93M |
| EPS (Basic) | $1.46 |
| EPS (Diluted) | $1.43 |
| Shares Outstanding (Basic) | 154.96M |
| Shares Outstanding (Diluted) | 158.06M |
Key Highlights
- 1Revenue increased by 9% to $2.24 billion in fiscal year 2015, driven by organic growth and acquisitions.
- 2Operating income grew by 7% to $266.5 million, reflecting efficient operations.
- 3Net income decreased by 13% to $225.9 million, largely due to a significant increase in income tax provision.
- 4Research and Development (R&D) expenses rose by 8% to $776.2 million, underscoring investment in innovation.
- 5The company maintained a strong focus on its time-based revenue model, with approximately 90% of revenue derived from this source.
- 6Synopsys continued its share repurchase program, repurchasing approximately $500 million worth of stock during the period.
- 7The company is facing ongoing patent litigation with Mentor Graphics Corporation, which resulted in a jury verdict of approximately $36 million in damages.